The lancet. Gastroenterology & hepatology
-
Lancet Gastroenterol Hepatol · Aug 2021
Randomized Controlled Trial Multicenter StudyEfficacy and safety of adalimumab in paediatric patients with moderate-to-severe ulcerative colitis (ENVISION I): a randomised, controlled, phase 3 study.
Biologic treatment options are limited for children with ulcerative colitis. The aim of this study was to assess the safety and efficacy of adalimumab in children with moderate-to-severe ulcerative colitis. ⋯ AbbVie.